Route cleared for GAIL equity in TruAlt’s Leafiniti Bioenergy

In an important development, GAIL (India) Ltd has received approval from the Department of Investment and Public Asset Management (DIPAM) for its proposed equity participation in Leafiniti Bioenergy Pvt Ltd. This marks a key step in the company’s strategic expansion into the bioenergy sector.

The approval was communicated through the Ministry of Petroleum and Natural Gas (MoPNG) vide its letter dated February 4, 2026, conveying DIPAM’s concurrence issued through an Office Memorandum dated January 22, 2026.

This regulatory clearance follows execution of a Share Subscription-cum-Shareholders Agreement by GAIL with Leafiniti Bioenergy on August 11, 2025. This was earlier disclosed to the stock exchanges in line with regulatory requirements.

In August last year, GAIL India signed an agreement to enter into a strategic joint venture with TruAlt Bioenergy Ltd to to accelerate the development of India’s Compressed Bio-Gas (CBG) sector. Leafniti Bioenergy is a 100% subsidiary of TruAlt.

The equity investment underscores GAIL’s continued focus on diversifying its energy portfolio and strengthening its presence in renewable and clean energy segments. Leafiniti Bioenergy operates in the bioenergy space, which aligns with GAIL’s long-term strategy to support India’s energy transition and sustainability goals.

The disclosure has been made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

As per the agreement signed with TruAlt, GAIL was to acquire 49% equity stakes in Leafiniti Bioenergy which owns and operates 10.2 TPD press-mud based CBG plant in Karnataka since 2021.